Hologic Non Recurring vs Ebit Analysis

HOLX Stock

USD 75.98 0.27 0.36%

Hologic financial indicator trend analysis is much more than just examining Hologic latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hologic is a good investment. Please check the relationship between Hologic Non Recurring and its Ebit accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Non Recurring vs Ebit

Non Recurring vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hologic Non Recurring account and Ebit. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Hologic's Non Recurring and Ebit is -0.19. Overlapping area represents the amount of variation of Non Recurring that can explain the historical movement of Ebit in the same time period over historical financial statements of Hologic, assuming nothing else is changed. The correlation between historical values of Hologic's Non Recurring and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Recurring of Hologic are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Non Recurring i.e., Hologic's Non Recurring and Ebit go up and down completely randomly.

Correlation Coefficient

-0.19

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Non Recurring

Ebit

Most indicators from Hologic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hologic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.At this time, Hologic's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.11 in 2024, whereas Tax Provision is likely to drop slightly above 138.5 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	95.1M	111.1M	127.8M	110.1M
Depreciation And Amortization	464.5M	323.4M	371.9M	390.5M

Interest Expense Depreciation And Amortization

Hologic fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Total Current Assets	Non Currrent Assets Other	Other Current Assets	Other Current Liab	Accounts Payable	Short Term Debt	Property Plant And Equipment Gross	Short Term Investments	Common Stock	Other Assets
Total Assets		0.63	0.59	0.77	0.94	0.14	0.18	0.61	0.66	0.61	0.55	0.67	0.55	0.77	0.48	0.61	0.69	0.46	0.52	0.09	0.53	0.11	0.69	-0.43	0.75	0.38
Short Long Term Debt Total	0.63		0.23	0.02	0.58	0.8	-0.56	-0.14	0.98	-0.14	0.13	0.83	0.97	0.07	0.9	1.0	-0.07	-0.01	0.03	0.4	-0.21	0.25	-0.06	-0.63	0.71	0.01
Total Current Liabilities	0.59	0.23		0.57	0.75	-0.04	0.15	0.4	0.29	0.4	0.69	0.56	0.02	0.59	0.33	0.22	0.51	0.45	0.32	0.2	0.47	0.72	0.5	-0.39	0.65	0.35
Total Stockholder Equity	0.77	0.02	0.57		0.74	-0.51	0.75	0.93	0.09	0.93	0.64	0.26	-0.08	0.97	-0.12	0.0	0.98	0.63	0.69	-0.16	0.85	-0.08	0.97	0.02	0.49	0.52
Property Plant And Equipment Net	0.94	0.58	0.75	0.74		0.14	0.13	0.55	0.6	0.55	0.73	0.76	0.45	0.78	0.54	0.55	0.68	0.53	0.51	0.22	0.53	0.25	0.67	-0.48	0.84	0.45
Net Debt	0.14	0.8	-0.04	-0.51	0.14		-0.91	-0.67	0.76	-0.67	-0.15	0.53	0.83	-0.46	0.84	0.81	-0.6	-0.34	-0.29	0.51	-0.65	0.29	-0.58	-0.58	0.28	-0.23
Retained Earnings	0.18	-0.56	0.15	0.75	0.13	-0.91		0.82	-0.5	0.82	0.33	-0.36	-0.6	0.67	-0.73	-0.57	0.79	0.5	0.58	-0.39	0.74	-0.33	0.79	0.57	-0.09	0.42
Cash	0.61	-0.14	0.4	0.93	0.55	-0.67	0.82		-0.12	1.0	0.44	0.05	-0.22	0.91	-0.32	-0.18	0.97	0.59	0.51	-0.43	0.92	-0.19	0.93	0.1	0.29	0.41
Non Current Assets Total	0.66	0.98	0.29	0.09	0.6	0.76	-0.5	-0.12		-0.12	0.16	0.85	0.94	0.11	0.89	0.99	-0.04	-0.02	0.12	0.43	-0.19	0.3	-0.01	-0.61	0.74	0.01
Cash And Short Term Investments	0.61	-0.14	0.4	0.93	0.55	-0.67	0.82	1.0	-0.12		0.44	0.05	-0.22	0.91	-0.32	-0.18	0.97	0.59	0.51	-0.43	0.92	-0.19	0.93	0.1	0.29	0.41
Net Receivables	0.55	0.13	0.69	0.64	0.73	-0.15	0.33	0.44	0.16	0.44		0.47	-0.02	0.69	0.17	0.12	0.64	0.8	0.6	0.42	0.44	0.14	0.64	0.06	0.63	0.84
Common Stock Shares Outstanding	0.67	0.83	0.56	0.26	0.76	0.53	-0.36	0.05	0.85	0.05	0.47		0.7	0.33	0.88	0.83	0.17	0.17	0.14	0.48	0.02	0.42	0.17	-0.64	0.96	0.17
Non Current Liabilities Total	0.55	0.97	0.02	-0.08	0.45	0.83	-0.6	-0.22	0.94	-0.22	-0.02	0.7		-0.04	0.85	0.97	-0.17	-0.11	-0.02	0.34	-0.3	0.09	-0.15	-0.58	0.56	-0.07
Inventory	0.77	0.07	0.59	0.97	0.78	-0.46	0.67	0.91	0.11	0.91	0.69	0.33	-0.04		-0.04	0.04	0.97	0.63	0.63	-0.09	0.83	-0.09	0.93	-0.06	0.56	0.53
Other Stockholder Equity	0.48	0.9	0.33	-0.12	0.54	0.84	-0.73	-0.32	0.89	-0.32	0.17	0.88	0.85	-0.04		0.91	-0.22	-0.13	-0.13	0.52	-0.32	0.42	-0.21	-0.76	0.72	-0.08
Total Liab	0.61	1.0	0.22	0.0	0.55	0.81	-0.57	-0.18	0.99	-0.18	0.12	0.83	0.97	0.04	0.91		-0.1	-0.04	0.04	0.42	-0.25	0.28	-0.09	-0.62	0.7	0.0
Total Current Assets	0.69	-0.07	0.51	0.98	0.68	-0.6	0.79	0.97	-0.04	0.97	0.64	0.17	-0.17	0.97	-0.22	-0.1		0.68	0.65	-0.23	0.89	-0.15	0.98	0.1	0.42	0.55
Non Currrent Assets Other	0.46	-0.01	0.45	0.63	0.53	-0.34	0.5	0.59	-0.02	0.59	0.8	0.17	-0.11	0.63	-0.13	-0.04	0.68		0.4	0.02	0.58	-0.07	0.62	0.29	0.34	0.94
Other Current Assets	0.52	0.03	0.32	0.69	0.51	-0.29	0.58	0.51	0.12	0.51	0.6	0.14	-0.02	0.63	-0.13	0.04	0.65	0.4		0.26	0.37	-0.18	0.78	0.32	0.33	0.48
Other Current Liab	0.09	0.4	0.2	-0.16	0.22	0.51	-0.39	-0.43	0.43	-0.43	0.42	0.48	0.34	-0.09	0.52	0.42	-0.23	0.02	0.26		-0.58	0.18	-0.16	0.0	0.41	0.3
Accounts Payable	0.53	-0.21	0.47	0.85	0.53	-0.65	0.74	0.92	-0.19	0.92	0.44	0.02	-0.3	0.83	-0.32	-0.25	0.89	0.58	0.37	-0.58		-0.05	0.82	-0.04	0.24	0.34
Short Term Debt	0.11	0.25	0.72	-0.08	0.25	0.29	-0.33	-0.19	0.3	-0.19	0.14	0.42	0.09	-0.09	0.42	0.28	-0.15	-0.07	-0.18	0.18	-0.05		-0.14	-0.47	0.33	-0.14
Property Plant And Equipment Gross	0.69	-0.06	0.5	0.97	0.67	-0.58	0.79	0.93	-0.01	0.93	0.64	0.17	-0.15	0.93	-0.21	-0.09	0.98	0.62	0.78	-0.16	0.82	-0.14		0.15	0.42	0.53
Short Term Investments	-0.43	-0.63	-0.39	0.02	-0.48	-0.58	0.57	0.1	-0.61	0.1	0.06	-0.64	-0.58	-0.06	-0.76	-0.62	0.1	0.29	0.32	0.0	-0.04	-0.47	0.15		-0.5	0.43
Common Stock	0.75	0.71	0.65	0.49	0.84	0.28	-0.09	0.29	0.74	0.29	0.63	0.96	0.56	0.56	0.72	0.7	0.42	0.34	0.33	0.41	0.24	0.33	0.42	-0.5		0.33
Other Assets	0.38	0.01	0.35	0.52	0.45	-0.23	0.42	0.41	0.01	0.41	0.84	0.17	-0.07	0.53	-0.08	0.0	0.55	0.94	0.48	0.3	0.34	-0.14	0.53	0.43	0.33

Click cells to compare fundamentals

Hologic Account Relationship Matchups

Hologic fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.2B	8.9B	9.1B	9.1B	10.5B	11.0B
Short Long Term Debt Total	3.0B	3.0B	2.8B	2.8B	3.2B	1.8B
Total Current Liabilities	1.2B	1.3B	937.7M	1.2B	1.4B	1.5B
Total Stockholder Equity	2.7B	4.2B	4.9B	5.0B	5.8B	6.1B
Property Plant And Equipment Net	491.5M	564.7M	481.6M	517M	594.6M	624.3M
Net Debt	2.3B	1.9B	483.9M	95.7M	110.1M	104.6M
Retained Earnings	(1.6B)	298.3M	1.6B	2.1B	1.9B	1.9B
Cash	701M	1.2B	2.3B	2.7B	3.1B	3.3B
Non Current Assets Total	5.0B	5.8B	5.2B	5.0B	5.7B	3.0B
Cash And Short Term Investments	701M	1.2B	2.3B	2.7B	3.1B	3.3B
Net Receivables	1.0B	942.7M	617.6M	625.6M	719.4M	755.4M
Common Stock Shares Outstanding	264.6M	259.7M	253.8M	248.8M	286.2M	167.9M
Liabilities And Stockholders Equity	7.2B	8.9B	9.1B	9.1B	10.5B	11.0B
Non Current Liabilities Total	3.2B	3.4B	3.3B	2.9B	3.4B	2.0B
Inventory	395.1M	501.2M	623.7M	617.6M	710.2M	745.8M
Other Stockholder Equity	4.3B	4.0B	3.5B	3.1B	3.6B	2.5B
Total Liab	4.5B	4.7B	4.2B	4.1B	4.7B	2.4B
Total Current Assets	2.2B	3.2B	3.9B	4.2B	4.8B	5.1B
Non Currrent Assets Other	489.7M	214.3M	188.8M	267.9M	308.1M	323.5M
Other Current Assets	97.3M	554.5M	281.2M	206.9M	237.9M	249.8M
Other Current Liab	549.5M	599.9M	538.5M	8.2M	9.4M	9.0M
Accounts Payable	178.8M	215.9M	197.7M	712.9M	819.8M	860.8M
Short Term Debt	324.9M	313M	15M	287M	330.1M	177.8M
Property Plant And Equipment Gross	572.2M	1.3B	1.3B	1.3B	1.5B	1.6B
Accumulated Other Comprehensive Income	(49.7M)	(59.1M)	(238.2M)	(147.6M)	(132.8M)	(126.2M)
Other Assets	424.5M	245.7M	210.5M	179M	205.9M	216.1M
Long Term Debt	2.7B	2.7B	2.8B	2.5B	2.9B	2.2B
Treasury Stock	(926M)	(1.6B)	(2.0B)	(2.5B)	(2.3B)	(2.2B)
Intangible Assets	1.3B	1.7B	1.3B	888.6M	1.0B	1.8B
Property Plant Equipment	491.5M	564.7M	481.6M	579.7M	666.7M	337.5M
Current Deferred Revenue	186.1M	198M	186.5M	199.2M	229.1M	128.0M
Good Will	2.7B	3.3B	3.2B	3.3B	3.8B	2.3B
Other Liab	429.3M	662.3M	448.9M	321.5M	369.7M	441.1M
Net Tangible Assets	(1.3B)	(722.2M)	359.1M	847M	974.1M	1.0B
Long Term Debt Total	2.8B	2.7B	2.7B	2.8B	3.2B	3.2B
Capital Surpluse	5.8B	5.9B	6.0B	6.0B	6.9B	6.1B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:

How To Invest In Hologic

Details

Is Hologic Stock a good investment?

Details

What is Hologic's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Hologic Stock analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.

	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	FinTech Suite Use AI to screen and filter profitable investment opportunities

Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.373

Earnings Share

2.11

Revenue Per Share

16.228

Quarterly Revenue Growth

(0.06)

Return On Assets

0.0649

The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hologic Non Recurring vs Ebit Analysis

Non Recurring vs Ebit

Non Recurring vs Ebit Correlation Analysis

Correlation Coefficient

Non Recurring

Ebit

Hologic fundamental ratios Correlations

Hologic Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Hologic fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Hologic Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Non Current Assets Total
Non Current Assets Total	+ 0.98	Short Long Term Debt Total
Total Current Assets	+ 0.98	Total Stockholder Equity
Property Plant And Equipment Gross	+ 0.98	Total Current Assets

Retained Earnings	- 0.91	Net Debt
Short Term Investments	- 0.76	Other Stockholder Equity
Other Stockholder Equity	- 0.73	Retained Earnings
Cash And Short Term Investments	- 0.67	Net Debt
Cash	- 0.67	Net Debt
Accounts Payable	- 0.65	Net Debt